A review in 'Science' reviews the new generation of drugs against obesity. It also warns that the patents of semaglutide generics will delay their arrival in Spain until 2031, although they are already sold in India and Brazil.
Advertisement
Drugs that come after Ozempec: seek to thwart more, lose less muscle and avoid bounce effect
A review in 'Science' reviews the new generation of drugs against obesity. It also warns that the patents of semaglutide generics will delay their arrival in Spain until 2031, although they are already sold in India and Brazil.
